PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Durham, NC, USA.\', \'Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, DUMC Box 103861, Durham, NC, 27710, USA. tian.zhang2@duke.edu.\', \'Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA. tian.zhang2@duke.edu.\', \'Department of Radiation Oncology, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.\', \'Pelotonia Institute for Immuno-Oncology, The OH State University Comprehensive Cancer Center - James, Columbus, OH, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13045-021-01046-w
?:hasPublicationType
?:journal
  • Journal of hematology & oncology
is ?:pmid of
?:pmid
?:pmid
  • 33640005
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 vaccines for patients with cancer: benefits likely outweigh risks.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all